1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

---

For the cancer treatment an antibody called as I-006 is getting evaluated at clinical level. It is witnessed that the antibody which is getting evaluated for having anti-cancer activity may have substantial efficacy against severe acute ...

Read More

---

Pancreatic Cancer Treatment with Novel ADC Immunotherapy Strategy

Release Date: 14 November 2020

Among all the cancer types that have been diagnosed and treated, pancreatic cancer is one of the most difficult cancer to treat as the delivery of the drugs is very complex when compared with other cancers. But a group of researchers fro...

Read More

---

Evinacumab Monoclonal Antibody to Reduce the Chance of Cardiovascular Diseases in Patients

Release Date: 13 November 2020

High cholesterol is known to be very unhealthy is present in high amount in a body. Also, increase in the amount of LDL is considered to be one of the most important markers of heart diseases. Therefore, most of the drugs that are develo...

Read More

---

Hyperactivity Disorders in Adults Controlled with Long Acting Stimulants

Release Date: 13 November 2020

It has been found that the action of long-acting stimulants can improve the overall safety in the patients suffering from hyperactivity disorders. A group of researchers researched about the activity of 2 long-acting psychostimulants in ...

Read More

---

Dapagliflozin and Exenatide to Improve Health Conditions in Patients Suffering from Type 2 Diabetes

Release Date: 13 November 2020

Researchers have tested a drug combination called as dapagliflozin and exenatide in the treatment of the patients suffering from type 2 diabetes. Although there are several different drugs that are used for the treatment of type 2 diabet...

Read More

---

Antibody Market to get Visualized as Potent Therapy against Viruses

Release Date: 13 November 2020

Antibody treatment for the human diseases is getting appreciated for very long now. Now-a-days, researchers are more inclined towards developing antibodies for the treatment of patients suffering from Covid-19 by using plasma therapy whi...

Read More

---

CT-P59 to Recover Patients Suffering from Covid-19

Release Date: 13 November 2020

An antibody developed against Covid-19 by South Korean researchers at Celltrion Inc showed minimum 44% improvement in the overall recovery time. The antibody developed by the researchers is called as CT-P59 and the researchers working on...

Read More

---

Nanoparticle and Desired Drug to Cross the Blood-Brain Barrier in case of Neurodegenerative Diseases

Release Date: 12 November 2020

Neurodegenerative diseases are the second most widely diagnosed disease after cancer across the globe, therefore, to tackle this a group of researchers from Institut national de la recherche scientifique (INRS) are now focused towards de...

Read More

---

Researchers Pushing the Therapeutics Industry by Introducing Microrobots to the Sector

Release Date: 12 November 2020

With time and advancement in the therapeutics industry, it is becoming clearer that tiny as well as primitive robots can soon invade the people’s bodies. A group of researchers have showed that tiny bots can be injected with syring...

Read More

---

Microrobots to make Therapeutic Challenges with Treating Colon Disease to Decline

Release Date: 12 November 2020

A novel micromachine developed by the researchers from Purdue University are on the edge of revolutionizing the targeted drug delivery system to the colon. Colon among all the parts of the body provides an easy introduction of the drug a...

Read More

---

Nanoparticles Delivers Promising Results in Developing Anti-Cancer Activity

Release Date: 12 November 2020

Cancer now-a-days by the researchers working at the University of Southern California are conducting researchers at the nano-scale. The group of researchers working at the respective university have developed a nanoparticle micelle that ...

Read More

---

GPCR and RTK Targeting by Anti-Depressant Drug for Sarcoma in Children

Release Date: 12 November 2020

Cancer, among all the diseases is one of the most complex disease to treat. Therefore, number of researchers across the globe are now inclined towards conducting research that could lead to the development of efficient cancer therapies e...

Read More

---

Researchers Inclined towards Incorporating Riboswitches in Therapeutics Industry

Release Date: 11 November 2020

A group of researchers from National Centre for Biological Sciences, Bengaluru is focused on developing a novel type of riboswitch in case of bacteria. As per the researchers, the developed riboswitch by them can bind to iron which entir...

Read More

---

Novel Technology to get Prominent Fame in the Overall Therapeutics Industry

Release Date: 11 November 2020

A group of researchers are focused towards delivering the desired drugs through the way of gastrointestinal tract which is considered to be a formidable challenge as the lining of the gastrointestinal tract is covered with mucosa which a...

Read More

---

Theragrippers Changing Drug Release Industry by its Promising Activities

Release Date: 11 November 2020

In case of delivery of drugs to the desired location, researchers all across the globe are concentrated towards the adoption of nano- or microfabricated devices including protein encapsulating microparticles, microneedles for transdermal...

Read More

---

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |